Clonmel Healthcare’s newest campaign where they are pleased to unveil the new packaging for Clonfolic.
Clonfolic is the market leading brand1 of Folic Acid in Ireland. This latest Clonfolic campaign aims to educate all women who are capable of conceiving about the importance of taking Folic Acid in helping to prevent Spina Bifida and other NTDs2 during pregnancy.
In addition to this, with almost 50% of pregnancies unplanned, it informs of the importance of taking 0.4 mg of folic acid every day for at least 14 weeks before you become pregnant and continue taking it for at least the first 12 weeks of pregnancy.
This campaign is in support of The Clonmel Healthcare consumer campaign
LADIES, IN ALL HONESTY, YOU ACTUALLY NEED FA*
Visit the NEW Clonfolic website for further information: www.clonfolic.ie
Clonmel Healthcare has a large portfolio of products covering three distinct business units; prescription medicines, specialty medicines and over the counter consumer division, and supplies the Irish market, through pharmacists and medical professionals.
Clonmel Healthcare is committed to supplying an extensive range of quality, and less expensive prescription medicines and specialised products in the therapeutic areas of neurology, psychiatry, diabetes and osteoporosis. The company is also a leader in over-the-counter medicines specialising in original, stand-alone, international brands that serve the mother and baby, pain relief and health supplement sectors.
Established in 1970, and with 50 years’ experience, Clonmel Healthcare now places 12.2 million packs of medicine into the Irish market every year, making the company one of the top two suppliers in Ireland. In 2016, Clonmel Healthcare launched its biosimilar division and intends to offer a comprehensive range of product into this space over the next couple of years.
All females who are capable of conceiving should take one tablet (0.4 mg) daily. If you are planning a pregnancy you should begin taking Clonfolic at least 14 weeks before you become pregnant and continue taking it for at least the first 12 weeks of pregnancy
A copy of the summary of product characteristics is available upon request.
PA 126/95/1 PA Holder: Clonmel Healthcare Ltd., Clonmel, Co. Tipperary
Medicinal product for supply through general sales
Ref 1: IQVIA, IRLP audit, units, MAT Jan 20.
Ref 2: NTDs (Neural Tube Defects).
Date prepared: July 2020